Key result
A nomogram-based scoring tool incorporating clinical and laboratory features predicted pulmonary embolism with an AUC of 0.688 (95% CI 0.653-0.723; P<0.01) in the validation cohort.
Why the study?
Pulmonary embolisms are clinically challenging due to high morbidity and mortality, creating a need for a scoring tool to predict risk and improve clinical management.
Does a nomogram-based scoring tool accurately predict the risk of pulmonary embolism in hospitalized patients with suspected PE?
Observational (n=1,480)
No
Does a nomogram-based scoring tool accurately predict the risk of pulmonary embolism in hospitalized patients with suspected PE?
Effect estimate: AUC 0.688 (95% CI 0.653-0.723)
p-value: p=< 0.01
A newly developed nomogram using routine clinical and laboratory parameters demonstrated moderate predictive ability for pulmonary embolism, which may help reduce unnecessary CTPA scans.
Moderate accuracy for PE risk; hypothesis-generating and should not yet change practice or reduce CTPA use.
Background: Pulmonary embolisms (PEs) are clinically challenging because of their high morbidity and mortality. This study aimed to develop a scoring tool for predicting PEs to improve their clinical management. Methods: Clinical, laboratory, and imaging parameters were retrospectively collected from suspected PE patients who had cough or chest pain and were hospitalized in West China Hospital of Sichuan University from May 2015 to April 2020. The final diagnosis of PE was defined based on findings from computed tomographic pulmonary angiography (CTPA). In this study, patients were randomly divided 2:1 into derivation and validation cohorts, which were used to create and validate, respectively, a nomogram. Model performance was estimated with the area under the receiver operating characteristic curve and a calibration curve. Results: Our study incorporated data on more than 100 features from 1480 patients (811 non-PE, 669 PE). The nomogram was constructed using important predictive features including D-dimer, APTT, FDP, platelet count, sodium, albumin and cholesterol and achieved AUC values of 0.692 with the derivation cohort (95% CI 0.688-0.696, P < 0.01) and 0.688 with the validation cohort (95% CI 0.653-0.723, P < 0.01). The calibration curve showed good agreement between the probability predicted by the nomogram and the actual probability. Conclusion: In this study, we successfully developed a nomogram that can predict the risk of PE, which can not only improve the clinical management of PE patients but also decrease unnecessary CTPA scans and their adverse effects.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2022) conducted an observational in Suspected pulmonary embolism (n=1,480). Nomogram-based scoring tool was evaluated on Prediction of pulmonary embolism (AUC 0.688, 95% CI 0.653-0.723, p=< 0.01). A nomogram-based scoring tool incorporating clinical and laboratory features predicted pulmonary embolism with an AUC of 0.688 (95% CI 0.653-0.723; P<0.01) in the validation cohort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: